HB 870
Effective date: 08/01/2026
INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
- Louisiana
- House / Assembly
- Introduced Feb 27, 2026
- Session 2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Louisiana’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
21 actions-
Effective date: 08/01/2026.
-
Sent to the Governor for executive approval.
-
Enrolled and signed by the Speaker of the House.
-
Conference Committee Report read, roll called, yeas 94, nays 0. The Conference Committee Report was adopted.
-
Conference Committee Report read; adopted by a vote of 36 yeas and 0 nays.
-
Conference committee report received.
-
Notice House Conference Committee members appointed.
-
Notice House rejected the Senate amendments.
-
Notice of Senate conferees appointed.
-
Scheduled for concurrence on 05/26/2026.
-
Senate floor amendments read and adopted. Read by title, passed by a vote of 33 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
-
Read by title and returned to the Calendar, subject to call.
-
Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
-
Reported with amendments.
-
Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
-
Called from the calendar.
-
Notice given.
-
Scheduled for floor debate on 04/09/2026.
-
Reported with amendments (10-0).
-
Prefiled.
-
First appeared in the Interim Calendar on 2/27/2026.